346 related articles for article (PubMed ID: 9334371)
1. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
Blachere NE; Li Z; Chandawarkar RY; Suto R; Jaikaria NS; Basu S; Udono H; Srivastava PK
J Exp Med; 1997 Oct; 186(8):1315-22. PubMed ID: 9334371
[TBL] [Abstract][Full Text] [Related]
2. Cross-presentation of human melanoma peptide antigen MART-1 to CTLs from in vitro reconstituted gp96/MART-1 complexes.
Staib F; Distler M; Bethke K; Schmitt U; Galle PR; Heike M
Cancer Immun; 2004 Apr; 4():3. PubMed ID: 15086273
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins.
Breloer M; Fleischer B; von Bonin A
J Immunol; 1999 Mar; 162(6):3141-7. PubMed ID: 10092763
[TBL] [Abstract][Full Text] [Related]
4. Activation of cytotoxic T cells in vitro by recombinant gp96 fusion proteins irrespective of the 'fused' antigenic peptide sequence.
Moré S; Breloer M; Fleischer B; von Bonin A
Immunol Lett; 1999 Aug; 69(2):275-82. PubMed ID: 10482363
[TBL] [Abstract][Full Text] [Related]
5. Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
Ménoret A; Peng P; Srivastava PK
Biochem Biophys Res Commun; 1999 Sep; 262(3):813-8. PubMed ID: 10471407
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanticity of alpha 2-macroglobulin, an independent ligand for the heat shock protein receptor CD91.
Binder RJ; Karimeddini D; Srivastava PK
J Immunol; 2001 Apr; 166(8):4968-72. PubMed ID: 11290775
[TBL] [Abstract][Full Text] [Related]
7. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
[TBL] [Abstract][Full Text] [Related]
8. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
[TBL] [Abstract][Full Text] [Related]
9. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
[TBL] [Abstract][Full Text] [Related]
10. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
11. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
Arnold D; Wahl C; Faath S; Rammensee HG; Schild H
J Exp Med; 1997 Aug; 186(3):461-6. PubMed ID: 9236199
[TBL] [Abstract][Full Text] [Related]
12. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
Arnold D; Faath S; Rammensee H; Schild H
J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
[TBL] [Abstract][Full Text] [Related]
13. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.
Suto R; Srivastava PK
Science; 1995 Sep; 269(5230):1585-8. PubMed ID: 7545313
[TBL] [Abstract][Full Text] [Related]
14. [Role of heat shock protein-peptide complexes on tumor and infectious diseases immunity].
Meng SD; Gao F; Tien P
Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):425-8. PubMed ID: 11051811
[TBL] [Abstract][Full Text] [Related]
15. Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins.
Binder RJ; Kelly JB; Vatner RE; Srivastava PK
J Immunol; 2007 Dec; 179(11):7254-61. PubMed ID: 18025167
[TBL] [Abstract][Full Text] [Related]
16. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
Davila E; Kennedy R; Celis E
Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
[TBL] [Abstract][Full Text] [Related]
17. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.
Basu S; Binder RJ; Ramalingam T; Srivastava PK
Immunity; 2001 Mar; 14(3):303-13. PubMed ID: 11290339
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.
Lu WW; Zhang H; Li YM; Ji F
World J Gastroenterol; 2017 Jun; 23(24):4390-4398. PubMed ID: 28706421
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes.
Wang XH; Qin Y; Hu MH; Xie Y
Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645
[TBL] [Abstract][Full Text] [Related]
20. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway.
Kurotaki T; Tamura Y; Ueda G; Oura J; Kutomi G; Hirohashi Y; Sahara H; Torigoe T; Hiratsuka H; Sunakawa H; Hirata K; Sato N
J Immunol; 2007 Aug; 179(3):1803-13. PubMed ID: 17641047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
